IFN-γ is essential for alveolar macrophage–driven pulmonary inflammation in macrophage activation syndrome
Authors:
- Denny K. GaoDGDenny K. Gao
- Nathan SalomonisNSNathan Salomonis
- Maggie HenderlightMHMaggie Henderlight
- Christopher WoodsCWChristopher Woods
- Kairavee ThakkarKTKairavee Thakkar
- Alexei A. GromAGAlexei A. Grom
- Sherry ThorntonSTSherry Thornton
- Michael B. JordanMJMichael B. Jordan
- Kathryn A. Wikenheiser-BrokampKWKathryn A. Wikenheiser-Brokamp
- Grant S. SchulertGSGrant S. Schulert
Open Access
- 8 September 2021
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (17)
Abstract
Macrophage activation syndrome (MAS) is a life-threatening cytokine storm complicating systemic juvenile idiopathic arthritis (SJIA) driven by IFN-γ. SJIA and MAS are also associated with an unexplained emerging inflammatory lung disease (SJIA-LD), with our recent work supporting pulmonary activation of IFN-γ pathways pathologically linking SJIA-LD and MAS. Our objective was to mechanistically define the potentially novel observation of pulmonary inflammation in the TLR9 mouse model of MAS. In acute MAS, lungs exhibit mild but diffuse CD4-predominant, perivascular interstitial inflammation with elevated IFN-γ, IFN-induced chemokines, and alveolar macrophage (AMϕ) expression of IFN-γ–induced genes. Single-cell RNA sequencing confirmed IFN-driven transcriptional changes across lung cell types with myeloid expansion and detection of MAS-specific macrophage populations. Systemic MAS resolution was associated with increased AMϕ and interstitial lymphocytic infiltration. AMϕ transcriptomic analysis confirmed IFN-γ–induced proinflammatory polarization during acute MAS, which switches toward an antiinflammatory phenotype after systemic MAS resolution. Interestingly, recurrent MAS led to increased alveolar inflammation and lung injury, and it reset AMϕ polarization toward a proinflammatory state. Furthermore, in mice bearing macrophages insensitive to IFN-γ, both systemic features of MAS and pulmonary inflammation were attenuated. These findings demonstrate that experimental MAS induces IFN-γ–driven pulmonary inflammation replicating key features of SJIA-LD and provides a model system for testing potentially novel treatments directed toward SJIA-LD.Keywords
Funding Information
- National Institutes of Health (AR072075,AR070549)
- Cincinnati Children’s Research Foundation (ARC Grant)
- Jellin Family Foundation (Donation)
This publication has 40 references indexed in Scilit:
- Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypesBMC Immunology, 2013
- Inherited defects causing hemophagocytic lymphohistiocytic syndromeAnnals of the New York Academy of Sciences, 2011
- Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in miceJournal of Clinical Investigation, 2011
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)Annals of the Rheumatic Diseases, 2011
- Role of Krüppel-like factors in leukocyte development, function, and diseaseBlood, 2010
- The molecular basis of pulmonary alveolar proteinosisClinical Immunology, 2010
- Mice with a Selective Impairment of IFN-γ Signaling in Macrophage Lineage Cells Demonstrate the Critical Role of IFN-γ–Activated Macrophages for the Control of Protozoan Parasitic Infections In VivoThe Journal of Immunology, 2009
- Neutrophil-mediated lung permeability and host defense proteinsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA Journal of Experimental Medicine, 2008
- Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRα gene in the X chromosome pseudoautosomal region 1Journal of Experimental Medicine, 2008